This loss of heterozygosity has been found to be associated with a decrease in GAS7 transcription in lung cancer patients, indicating a potential role for GAS7 as a tumor suppressor in lung cancer [2, 3]. This evidence concerns the gene GAS7 and lung carcinoma.